tiprankstipranks
Decision Diagnostics Corp (DECN)
OTHER OTC:DECN
US Market

Decision Diagnostics (DECN) Price & Analysis

86 Followers

DECN Stock Chart & Stats

<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)

DECN FAQ

What was Decision Diagnostics Corp’s price range in the past 12 months?
Currently, no data Available
What is Decision Diagnostics Corp’s market cap?
Decision Diagnostics Corp’s market cap is $380.00.
    When is Decision Diagnostics Corp’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Decision Diagnostics Corp’s earnings last quarter?
    Currently, no data Available
    Is Decision Diagnostics Corp overvalued?
    According to Wall Street analysts Decision Diagnostics Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Decision Diagnostics Corp pay dividends?
      Decision Diagnostics Corp does not currently pay dividends.
      What is Decision Diagnostics Corp’s EPS estimate?
      Decision Diagnostics Corp’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Decision Diagnostics Corp have?
      Decision Diagnostics Corp has 380,486,150 shares outstanding.
        What happened to Decision Diagnostics Corp’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Decision Diagnostics Corp?
        Currently, no hedge funds are holding shares in DECN
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          Decision Diagnostics Corp

          Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses. They also facilitate direct-to-patient logistics for diabetes programs and concentrate on creating mobile-centric e-health products and associated technological innovations. A key part of their product line involves glucose monitoring. This includes the GenUltimate! glucose test strips, classified as a Class II medical device for personal at-home human use. For animal health, they manufacture PetSure! glucose test strips, designed to measure glucose levels in dogs and cats and compatible with legacy Zoetis AlphaTrak glucometers. Additionally, they offer the proprietary GenUltimate! 4Pets Glucose system, which combines the GenUltimate! 4Pets strip with the Avantage meter, enabling glucose testing for canine, feline, and equine patients. Further glucose strip options include GenUltimate! Sure and GenUltimate! Precis. Beyond product development, Decision Diagnostics actively acquires and maintains a portfolio of intellectual property, spanning patents, trademarks, and specialized manufacturing equipment. Their software solutions include MD@Hand, a comprehensive management system for both inpatient and outpatient care; Practice Probe, a data mining utility designed to extract information from physician practice management systems; and ResidenceWare, a residential management system that streamlines communication between commercial or residential real estate managers and their tenants through networked applications. Ultimately, their EMR innovations provide crucial tools for physicians directly at the point of patient care. The company was originally known as InstaCare Corp. before officially changing its name to Decision Diagnostics Corp. in November 2011.
          Similar Stocks
          Company
          Price & Change
          Follow
          PharmaCyte Biotech
          Enveric Biosciences
          Bluejay Diagnostics
          SciSparc Ltd.
          Virax Biolabs Group Ltd. Class A
          Popular Stocks